Zoya N. Demidenko

Oncotarget, Inc.

$52,953

Attributed

$105,906

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

NIH$105,906 · 1

By mechanism

R41$105,906 · 1

Top collaborators

Misha Blagosklonny1 shared

Most similar at Oncotarget, Inc.

Same institution · by research overlap

Misha Blagosklonny$52,953

Others in their field

Top investigators on “Angiogenesis”

David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
Martin Friedlander · Scripps Research Institute$48,350,175
Larry Arthur$33,866,306
Michael Simons · Yale University$30,647,106
Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588

Research focus

AngiogenesisBaseBlindnessCell LineCellsCollectionCountryDiabetic RetinopathyDrug DiscoveryDrug Evaluation, PreclinicalEpithelialEvaluationEyedropsFormulations, DrugGovernmentHypoxiaHypoxia Inducible FactorInhibitor/AntagonistInsulinInsulin AntagonistsInsulin-Like Growth Factor ILibrariesLicensingAge Related Macular Degeneration

Grant awards (1)

Drug discovery for diabetic retinopathy$105,906

R41 · FY2007 · EY · contact PI